B cell development in chromosome 22q11.2 deletion syndrome
- 1 February 2016
- journal article
- research article
- Published by Elsevier in Clinical Immunology
- Vol. 163, 1-9
Abstract
No abstract availableKeywords
Funding Information
- Baxalta
- NIH (P30-CA016520)
This publication has 58 references indexed in Scilit:
- Follicular helper T cells in immunity and systemic autoimmunityNature Reviews Rheumatology, 2012
- Flow Cytometric Analysis of TCR Vβ Repertoire in Patients with 22q11.2 Deletion SyndromeScandinavian Journal of Immunology, 2011
- Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+CD27+CD43+CD70−Journal of Experimental Medicine, 2011
- Secondary immunologic consequences in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome)Clinical Immunology, 2010
- Tbx1 controls cardiac neural crest cell migration during arch artery development by regulatingGbx2expression in the pharyngeal ectodermDevelopment, 2009
- Circulating CD21lowB cells in common variable immunodeficiency resemble tissue homing, innate-like B cellsProceedings of the National Academy of Sciences, 2009
- Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individualsJournal of Experimental Medicine, 2008
- T cell receptor Vβ repertoire of T lymphocytes and T regulatory cells by flow cytometric analysis in healthy childrenClinical and Experimental Immunology, 2007
- Replication history of B lymphocytes reveals homeostatic proliferation and extensive antigen-induced B cell expansionJournal of Experimental Medicine, 2007
- Mesodermal expression ofTbx1is necessary and sufficient for pharyngeal arch and cardiac outflow tract developmentDevelopment, 2006